Align gets FDA clearance for Invisalign treatment with mandibular advancement

Align Technology announced that the U.S. Food and Drug Administration has cleared Invisalign treatment with mandibular advancement for commercial availability in the U.S. As previously announced on March 5, 2017, Invisalign treatment with mandibular advancement is the first clear aligner solution for Class II correction in growing tween and teen patients that combines the benefits of the most advanced clear aligner system in the world with features for moving the lower jaw forward while simultaneously aligning the teeth. This new solution for Invisalign doctors offers a simpler, more efficient and patient-friendly treatment option than functional appliances typically used to treat teen Class II patients.
https://thefly.com/landingPageNews.php?id=2812631